Building India’s Bioeconomy Powerhouse: The 2035 Roadmap for Global Leadership in Biotechnology

“Indirect Tax I Indirect Tax Litigation I Customs & FTP I Central Licensing I Arbitration I Advisory”

Dated: 01.08.2026

Building India’s Bioeconomy Powerhouse: The 2035 Roadmap for Global Leadership in Biotechnology

India is poised to become a global leader in the bioeconomy, leveraging its scientific strengths, manufacturing capabilities, and policy vision. This article explores the strategic roadmap, key missions, and actionable steps outlined to transform India into a bioeconomy powerhouse by 2035.

The Bioeconomy Opportunity

India’s bioeconomy has grown from $10 billion in 2014 to $195.3 billion in 2025, now contributing 4.8% to national GDP. The vision is to scale this to $691 billion by 2035 and $2.6 trillion by 2047, creating over 30 million high-value jobs and positioning India among the world’s top three biotechnology powers.

Why Bioeconomy Matters

Economic Growth: Drives GDP and job creation.
Strategic Autonomy: Reduces dependence on imports for medicines, fertilizers, and industrial enzymes.
Public Health Security: Enables rapid response to pandemics and health threats.
Climate Resilience: Supports sustainable agriculture and green manufacturing.
Global Competitiveness: Positions India as a trusted supplier and innovator.

Strategic Pillars of the Roadmap

1. Mission-Driven National BioMissions

India will shift from fragmented programs to six flagship National BioMissions, each with clear outcomes by 2035:

GeneIndia: Affordable gene and cell therapies for Indian patients, leveraging population-scale genomics.
AgriBio 2.0: Climate-resilient, farmer-owned crop varieties and quality-assured bio-inputs to boost farm profitability and reduce chemical use.
BioX Foundry: Commercial-scale synthetic biology platforms, aiming for 100 SynBio startups.
One Health Grid: AI-assisted disease detection and coordinated response to infectious diseases and antimicrobial resistance.
Marine Biotechnology: Expansion of marine-derived exports and coastal bioeconomies through seaweed cultivation and marine bioproducts.
BioPharmaNext: Establishing India as a global hub for affordable, next-generation biologics, biosimilars, vaccines, and cell/gene therapeutics.

2. Empowered Governance and Data Infrastructure

Empowered Committee on National BioMissions: Drives coordination and fast-tracks decisions.
National BioData Council: Governs and standardizes biological and health data sharing.
BioEconomy Investment & Policy Forum: Aligns public and private investments and global partnerships.
Bio-IP Accelerated Pathway: Streamlines IP filing and commercialization for biotech innovations.

3. Financing and Incentives

₹50,000 Crore BioEconomy Growth Fund (2026–2035): Closes the gap between proof-of-concept and manufacturing scale, supporting biomanufacturing, advanced therapeutics, and synthetic biology.
Production-Linked Incentives (PLI): Encourages investment and export-driven growth in biomanufacturing.

4. Regulatory Reforms

Differentiated Approval Pathways: For frontier modalities like cell/gene therapies, synthetic biology, and AI-designed drugs.
Regulatory Sandboxes: Enable faster, risk-based approvals for innovative products.
Modernization of Regulatory Agencies: Upgrades to global standards for efficiency and scientific rigor.

5. Talent and Leadership Development

Strengthening Education: Revitalizing undergraduate and postgraduate biotechnology programs.
Expanding Research Training: More PhD and postdoctoral fellowships, with international benchmarks.
Frontier Skills: Focus on bioinformatics, AI-driven biology, regulatory science, and advanced biomanufacturing.
Entrepreneurship Ecosystem: Enhanced mentorship, incubation, and commercialization support.

India’s Competitive Advantages

Deep Public Research Institutions: Strong backbone in science and technology.
World’s Largest Vaccine Manufacturing Base: Proven ability to deliver at scale.
Vibrant Startup Ecosystem: Over 10,000 biotech startups and 95+ incubation centers.
Rich Biodiversity: Marine, agricultural, and microbial resources.
Policy Momentum: BioE3 Policy aligns biotechnology with economic, environmental, and employment goals.

Global Benchmarking and Best Practices

United States: Whole-of-government approach to biomanufacturing.
European Union: Bioeconomy linked to industrial competitiveness and climate resilience.
China: Plan-led industrial scale-up and biosecurity integration.
Australia: Industry-aligned, translation-led model with strong regulatory and IP systems.

Risks of Inaction

Missed Economic Opportunity: Loss of market share and jobs.
National Security Risks: Continued reliance on imports for critical bio-products.
Environmental Setbacks: Slower adoption of green technologies.
Loss of Global Leadership: Falling behind in the biological century.

Conclusion

India’s roadmap to bioeconomy leadership is ambitious yet achievable. By executing mission-mode strategies, investing in talent and infrastructure, reforming regulations, and fostering innovation, India can shape the global bioeconomy, drive sustainable growth, and deliver solutions for its people and the world.

Listen to this on our #YouTube Channel

In case you face any issues related to Indirect Tax-Customs, GST, Foreign Trade Policy (FTP), Arbitration matters and Central Licensing and related advisory matters in India then please feel free to get in touch with SJ EXIM Services.

We offer Legal advice and litigation support in matters related to Indirect Tax-Customs, FTP, other Indirect Tax matters & Arbitration law, all sorts of Central licensing and related matters. Come and explore the new way of doing business with us!

Source: NITI Aayog

Disclaimer

Handy Download:

India’s Bioeconomy RoadmapDownload

Connect with us for more-

@ Team S J EXIM SERVICES, New Delhi, IN

CP: Ms. Shubhra Jha, Founder

Tel: +91-11-4999 2707 I +91-9999005693

Web: www.sjexim.services

EMAIL: operations@sjexim.services I shubhra@sjexim.services

Facebook: www.facebook.com/sjeximservices

LinkedIn: https://www.linkedin.com/company/90794255/admin/feed/posts/